These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. A combined gene expression and functional study reveals the crosstalk between N-Myc and differentiation-inducing microRNAs in neuroblastoma cells. Zhao Z; Ma X; Shelton SD; Sung DC; Li M; Hernandez D; Zhang M; Losiewicz MD; Chen Y; Pertsemlidis A; Yu X; Liu Y; Du L Oncotarget; 2016 Nov; 7(48):79372-79387. PubMed ID: 27764804 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-493-5p-mediated repression of the MYCN oncogene inhibits hepatic cancer cell growth and invasion. Yasukawa K; Liew LC; Hagiwara K; Hironaka-Mitsuhashi A; Qin XY; Furutani Y; Tanaka Y; Nakagama H; Kojima S; Kato T; Ochiya T; Gailhouste L Cancer Sci; 2020 Mar; 111(3):869-880. PubMed ID: 31883160 [TBL] [Abstract][Full Text] [Related]
12. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Ma L; Young J; Prabhala H; Pan E; Mestdagh P; Muth D; Teruya-Feldstein J; Reinhardt F; Onder TT; Valastyan S; Westermann F; Speleman F; Vandesompele J; Weinberg RA Nat Cell Biol; 2010 Mar; 12(3):247-56. PubMed ID: 20173740 [TBL] [Abstract][Full Text] [Related]
13. A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma. Shohet JM; Ghosh R; Coarfa C; Ludwig A; Benham AL; Chen Z; Patterson DM; Barbieri E; Mestdagh P; Sikorski DN; Milosavljevic A; Kim ES; Gunaratne PH Cancer Res; 2011 Jun; 71(11):3841-51. PubMed ID: 21498633 [TBL] [Abstract][Full Text] [Related]
14. MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas. Huang R; Cheung NK; Vider J; Cheung IY; Gerald WL; Tickoo SK; Holland EC; Blasberg RG FASEB J; 2011 Dec; 25(12):4138-49. PubMed ID: 21856782 [TBL] [Abstract][Full Text] [Related]
15. Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN. Ooi CY; Carter DR; Liu B; Mayoh C; Beckers A; Lalwani A; Nagy Z; De Brouwer S; Decaesteker B; Hung TT; Norris MD; Haber M; Liu T; De Preter K; Speleman F; Cheung BB; Marshall GM Cancer Res; 2018 Jun; 78(12):3122-3134. PubMed ID: 29610116 [TBL] [Abstract][Full Text] [Related]
16. Dickkopf-3 is regulated by the MYCN-induced miR-17-92 cluster in neuroblastoma. De Brouwer S; Mestdagh P; Lambertz I; Pattyn F; De Paepe A; Westermann F; Schroeder C; Schulte JH; Schramm A; De Preter K; Vandesompele J; Speleman F Int J Cancer; 2012 Jun; 130(11):2591-8. PubMed ID: 21796614 [TBL] [Abstract][Full Text] [Related]
17. The MYCN oncogene is a direct target of miR-34a. Wei JS; Song YK; Durinck S; Chen QR; Cheuk AT; Tsang P; Zhang Q; Thiele CJ; Slack A; Shohet J; Khan J Oncogene; 2008 Sep; 27(39):5204-13. PubMed ID: 18504438 [TBL] [Abstract][Full Text] [Related]